Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MSFT vs MRNA✓SelectedUSD · MRNAMSFT vs MRNA performance historyLatest closeAs of-1.12%11/16
Stock and ETF performance explorer

MSFT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+59.0%
MRNA return
-8.0%
Excess return
+67.0%
Maximum drawdown
-37.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.1%-3.6%+2.5%-1.0%
7D-5.0%-20.0%+15.0%-4.1%
30D-2.1%-1.3%-0.8%-2.1%
3M+4.8%+240.0%-235.2%-3.6%
6M+23.3%+339.0%-315.7%+10.1%
YTD+7.8%+630.0%-622.2%-9.6%
1Y+2.4%+769.1%-766.7%-16.0%
3Y+40.6%+181.2%-140.6%+24.1%
5Y+59.0%-8.1%+67.1%+50.8%
All+59.0%-8.0%+67.0%+50.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling